ENTRY       D08575                      Drug
NAME        Tetrabenazine (JAN/INN);
            Nitoman (TN);
            Xenazine (TN)
PRODUCT     XENAZINE (Lundbeck Pharmaceuticals LLC)
  GENERIC   TETRABENAZINE (Ajanta Pharma USA)
            TETRABENAZINE (Apotex Corp.)
            TETRABENAZINE (Bionpharma)
            TETRABENAZINE (Camber Pharmaceuticals)
            TETRABENAZINE (Dr. Reddys Laboratories)
            TETRABENAZINE (Golden State Medical Supply)
            TETRABENAZINE (Lupin Pharmaceuticals)
            TETRABENAZINE (Oceanside Pharmaceuticals)
            TETRABENAZINE (Slate Run Pharmaceuticals)
            TETRABENAZINE (Sun Pharmaceutical Industries)
            TETRABENAZINE (TAGI Pharma)
FORMULA     C19H27NO3
EXACT_MASS  317.1991
MOL_WEIGHT  317.4226
CLASS       Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02972  CBR substrate
REMARK      Same as: C11168
            Therapeutic category: 1190
            ATC code: N07XX06
            Product: D08575<JP/US>
EFFICACY    Neuroleptic, Vesicular monoamine transporter inhibitor
  DISEASE   Huntington's disease [DS:H00059]
TARGET      SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]
  PATHWAY   hsa04721(6571)  Synaptic vesicle cycle
            hsa04726(6571)  Serotonergic synapse
            hsa04728(6571)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565]; CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CBR [HSA:873 874]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07X OTHER NERVOUS SYSTEM DRUGS
                N07XX Other nervous system drugs
                 N07XX06 Tetrabenazine
                  D08575  Tetrabenazine (JAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Central Nervous System, Other
               Tetrabenazine
                D08575  Tetrabenazine (JAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D08575  Tetrabenazine (JAN/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D08575  Tetrabenazine
              DG01644  CYP2D6 substrate
               D08575  Tetrabenazine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D08575  Tetrabenazine
              DG02972  CBR substrate
               D08575  Tetrabenazine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC18
                SLC18A2 (VMAT2)
                 D08575  Tetrabenazine (JAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D08575
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D08575
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D08575
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08575
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D08575
DBLINKS     CAS: 58-46-8
            PubChem: 96025259
            ChEBI: 64028 9467
            LigandBox: D08575
            NIKKAJI: J4.592F
ATOM        23
            1   C1x C    24.2200  -16.8700
            2   C1y C    24.2200  -18.2700
            3   N1y N    25.4100  -18.9700
            4   C1x C    26.6700  -18.2700
            5   C1y C    26.6700  -16.8700
            6   C5x C    25.4100  -16.1700
            7   C8y C    23.0300  -18.9700
            8   C8y C    23.0300  -20.3700
            9   C1x C    24.2200  -21.0700
            10  C1x C    25.4100  -20.3700
            11  C8y C    20.5800  -18.9700
            12  C8y C    20.5800  -20.3700
            13  C8x C    21.7700  -21.0700
            14  C8x C    21.7700  -18.2700
            15  O5x O    25.4100  -14.7700
            16  C1b C    27.8600  -16.1700
            17  C1c C    29.0500  -16.8700
            18  C1a C    30.2400  -16.1700
            19  C1a C    29.0500  -18.2700
            20  O2a O    19.3900  -18.2700
            21  O2a O    19.3900  -21.0700
            22  C1a C    18.1300  -18.9700
            23  C1a C    18.1300  -20.3700
BOND        25
            1     5   6 1
            2     6   1 1
            3    11  12 2
            4    12  13 1
            5    13   8 2
            6     7  14 2
            7    14  11 1
            8     1   2 1
            9     6  15 2
            10    2   3 1
            11    5  16 1
            12    3   4 1
            13   16  17 1
            14    7   8 1
            15   17  18 1
            16    8   9 1
            17   17  19 1
            18    9  10 1
            19   11  20 1
            20   10   3 1
            21   12  21 1
            22    2   7 1
            23   20  22 1
            24    4   5 1
            25   21  23 1
///
